Jext Stungulyf, lausn í áfylltum lyfjapenna 150 míkróg আইসলণ্ড - আইসল্যান্ডীয় - LYFJASTOFNUN (Icelandic Medicines Agency)

jext stungulyf, lausn í áfylltum lyfjapenna 150 míkróg

alk-abelló a/s - adrenalinum bítartrat (epinephrinum bítartrat) - stungulyf, lausn í áfylltum lyfjapenna - 150 míkróg

Jext Stungulyf, lausn í áfylltum lyfjapenna 300 míkróg আইসলণ্ড - আইসল্যান্ডীয় - LYFJASTOFNUN (Icelandic Medicines Agency)

jext stungulyf, lausn í áfylltum lyfjapenna 300 míkróg

alk-abelló a/s - adrenalinum bítartrat (epinephrinum bítartrat) - stungulyf, lausn í áfylltum lyfjapenna - 300 míkróg

Nanogam Innrennslislyf, lausn 50 mg/ml আইসলণ্ড - আইসল্যান্ডীয় - LYFJASTOFNUN (Icelandic Medicines Agency)

nanogam innrennslislyf, lausn 50 mg/ml

prothya biosolutions netherlands b.v. - immunoglobulinum humanum inn - innrennslislyf, lausn - 50 mg/ml

Trixeo Aerosphere ইউরোপীয় ইউনিয়ন - আইসল্যান্ডীয় - EMA (European Medicines Agency)

trixeo aerosphere

astrazeneca ab - formoterol fumarate dihydrate, glycopyrronium bromide, budesonide - lungnasjúkdómur, langvarandi hindrandi - lyf til veikindi öndunarvegi sjúkdómum, - trixeo aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long acting beta2 agonist or combination of a long-acting beta2 agonist and a long acting muscarinic antagonist.

Riltrava Aerosphere ইউরোপীয় ইউনিয়ন - আইসল্যান্ডীয় - EMA (European Medicines Agency)

riltrava aerosphere

astrazeneca ab - budesonide, formoterol fumarate dihydrate, glycopyrronium bromide - lungnasjúkdómur, langvarandi hindrandi - lyf til veikindi öndunarvegi sjúkdómum, - riltrava aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2 agonist or combination of a long-acting beta2 agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5.